Chengdu-based biotech company is still to gain regulatory approval for its jab, which has been pre-ordered by global vaccine alliance GAVI

Company obtained a $360 million grant from the Coalition for Epidemic Preparedness Innovations, the disease research funding group, and its launch customer will be the Global Vaccine Alliance

Japan’s Eisai saw its US listed shares rise 56% – up by more than Biogen’s 38% jump after US regulators...

With unprecedented spikes in Covid infection rates and states reporting extreme shortages of vaccines, India banned the export of anti-viral drug Remdesivir and its ingredients on Sunday

(ATF) China’s vaccination campaign has taken a double body blow in recent days, with a leading scientist criticising...

(ATF) With vaccine diplomacy emerging as the centrepiece of the global foreign policy...

Serum Institute of India rejects claims of side-effects, says trial participant's lawsuit is 'malicious' and 'misconceived'

(ATF) Chinese vaccine stocks have plunged for two days straight this...

(ATF) High-yield corporate bonds joined a global stock rally after Pfizer said its Covid-19 vaccine had...

US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study after calls for greater transparency. 

Experts raised concerns about the Wuhan lab during an accreditation process - concerns that were amplified after the Covid-19 pandemic spread from the same city